(Q81858283)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15959825%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

title

Carboplatin plus paclitaxel in the treatment of advanced or recurrent endometrial carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15959825%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

main subject

endometrial carcinoma

1 reference

1 reference

1 reference

Chad M Michener

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15959825%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Gertrude Peterson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15959825%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Barbara Kulp

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15959825%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Kenneth D Webster

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15959825%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Maurie Markman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15959825%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

publication date

1 September 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15959825%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cancer Research and Clinical Oncology

12 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15959825%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

volume

131

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15959825%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15959825%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

page(s)

581-584

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15959825%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00432-005-0676-x

12 January 2020

exact match

0 references

cites work

Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: a phase II study

1 reference

12 December 2020

Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study.

1 reference

12 December 2020

Paclitaxel/carboplatin for the initial treatment of advanced ovarian cancer

1 reference

12 December 2020

Treatment of advanced or recurrent endometrial carcinoma with single-agent carboplatin

1 reference

12 December 2020

A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: a Gynecologic Oncology Group study

1 reference

12 December 2020

Prolonged remission of endometrial cancer with paclitaxel and carboplatin

1 reference

12 December 2020

A randomized comparison of doxorubicin alone versus doxorubicin plus cyclophosphamide in the management of advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group study

1 reference

12 December 2020

Phase I trial of escalating doses of paclitaxel combined with fixed doses of cisplatin and doxorubicin in advanced endometrial cancer and other gynecologic malignancies: a Gynecologic Oncology Group study

1 reference

12 December 2020

Phase 2 trial of liposomal doxorubicin (40 mg/m(2)) in platinum/paclitaxel-refractory ovarian and fallopian tube cancers and primary carcinoma of the peritoneum

1 reference

12 December 2020

Circadian-timed combination doxorubicin-cisplatin chemotherapy for advanced endometrial carcinoma. A phase II study of the Gynecologic Oncology Group.

1 reference

12 December 2020

Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamide

1 reference

12 December 2020

Paclitaxel and Cisplatin in Advanced or Recurrent Carcinoma of the Endometrium: Long-Term Results of a Phase II Multicenter Study

1 reference

12 December 2020

CA 125: a useful marker in endometrial carcinoma

1 reference

12 December 2020

Complete response of a stage IV uterine papillary serous carcinoma to neoadjuvant chemotherapy with Taxol and carboplatin

1 reference

12 December 2020

A trial of outpatient paclitaxel and carboplatin for advanced, recurrent, and histologic high-risk endometrial carcinoma: preliminary report.

1 reference

12 December 2020

A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer.

1 reference

12 December 2020

Activity of paclitaxel as second-line chemotherapy in endometrial carcinoma: a Gynecologic Oncology Group study

1 reference

12 December 2020

10.1007/S00432-005-0676-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15959825%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference